GURUGRAM, India--(BUSINESS WIRE)--Premas Biotech (https://www.premasbiotech.com/) announced today that its joint venture Oravax will initiate testing of their oral virus-like particle (VLP) vaccine candidate against Omicron variant of SARS-CoV 2 virus through preclinical, in vitro and challenge studies to assess its efficacy for the new mutant strain. Premas Biotech, Oramed Pharmaceuticals, MyMD Pharmaceuticals, and certain other shareholders formed Oravax Medical to bring an oral COVID-19 vaccine to the market
GURUGRAM, India--(BUSINESS WIRE)--Premas Biotech, a developer of novel biotherapeutic and vaccine candidates, announced today the development of an oral COVID-19 vaccine that has shown efficacy after a single dose, in conjunction with Oramed Pharmaceuticals Inc. (Nasdaq/TASE: ORMP).
Premas Biotech announced that its triple-antigen vaccine candidate for COVID-19 has induced neutralising immune response in mice during the four-week test of its SARS-CoV-2 vaccine candidate. The company is in talks with the concerned regulatory authorities to plan and initiate the next steps towards conducting human trials.
Premas Biotech’s triple-antigen vaccine candidate for COVID-19 has induced neutralizing immune response in mice during the four-week test of its SARS-CoV-2 vaccine candidate. The company is in talks with the regulatory authorities concerned to plan and initiate next steps towards conducting human trials.
GenScript Biotech Corporation (“GenScript”, Stock Code: 1548.HK), a leading global biotechnology company today announced a strategic sales distribution agreement, appointing Premas Life Sciences (PLS) as the exclusive technology and knowledge distributor of cPassTM SARS CoV-2 Neutralization Antibody Detection Kit in India.
The company said it had successfully completed the manufacturing process for the VLP (virus like particle) vaccine candidate, which includes three surface antigens from SARS-CoV-2.
Thorofare, New Jersey, Apr 06, 2020 (GLOBE NEWSWIRE via COMTEX) -- -- Successfully obtained clones for all three selected Coronavirus Antigens